• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.

作者信息

Finkelstein J S, Klibanski A, Neer R M, Greenspan S L, Rosenthal D I, Crowley W F

出版信息

Ann Intern Med. 1987 Mar;106(3):354-61. doi: 10.7326/0003-4819-106-3-.

DOI:10.7326/0003-4819-106-3-
PMID:3544993
Abstract

To assess the effect of testosterone deficiency on skeletal integrity in men, we determined bone density in 23 hypogonadal men with isolated gonadotropin-releasing hormone deficiency and compared those values with ones from controls. Cortical bone density, as assessed by single-photon absorptiometry of the nondominant radius, ranged from 0.57 to 0.86 g/cm2 (mean +/- SE, 0.71 +/- 0.02) in patients with fused epiphyses and from 0.57 to 0.67 g/cm2 (mean, 0.61 +/- 0.01) in patients with open epiphyses, both of which were significantly (p less than 0.001) lower than normal. Spinal trabecular bone density, as assessed by computed tomography, was similarly decreased (p less than 0.0001) and ranged from 42 to 177 mg K2HPO4/cm3 (mean, 112 +/- 7). Cortical bone density was at least 2 SD below normal in 16 of 23 men, and 8 men had spinal bone densities below the fracture threshold of 80 to 100 mg K2HPO4/cm3. Osteopenia was equally severe in men with immature and mature bone ages, suggesting that abnormal bone development plays an important role in the osteopenia of men with idiopathic hypogonadotropic hypogonadism.

摘要

相似文献

1
Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.
Ann Intern Med. 1987 Mar;106(3):354-61. doi: 10.7326/0003-4819-106-3-.
2
Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.
J Clin Endocrinol Metab. 1989 Oct;69(4):776-83. doi: 10.1210/jcem-69-4-776.
3
Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism.长期睾酮替代疗法对高促性腺激素性性腺功能减退男性骨矿物质含量的影响。
Andrologia. 2001 Jan;33(1):47-52. doi: 10.1046/j.1439-0272.2001.00417.x.
4
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.获得性性腺功能减退男性在睾酮给药期间骨密度和瘦体重增加。
J Clin Endocrinol Metab. 1996 Dec;81(12):4358-65. doi: 10.1210/jcem.81.12.8954042.
5
Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs.接受促性腺激素释放激素类似物治疗的前列腺癌男性患者性腺功能减退后的骨质流失。
J Clin Endocrinol Metab. 2002 Aug;87(8):3656-61. doi: 10.1210/jcem.87.8.8782.
6
Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.青春期延迟和性腺功能减退年轻男性的定量骨SPECT:对低骨密度治疗的意义
J Nucl Med. 1998 Jan;39(1):104-7.
7
Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility.成人迟发性特发性低促性腺激素性性腺功能减退——一种可治疗的男性不育症形式。
N Engl J Med. 1997 Feb 6;336(6):410-5. doi: 10.1056/NEJM199702063360604.
8
Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.睾酮替代疗法对性腺功能减退男性皮质骨和小梁骨矿物质密度、椎体面积及椎旁肌面积的影响。
Eur J Endocrinol. 1998 Jan;138(1):51-8. doi: 10.1530/eje.0.1380051.
9
The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.重型地中海贫血中性腺功能减退对骨质疏松症发展的影响:新的治疗方法。
Clin Endocrinol (Oxf). 1995 Mar;42(3):279-87. doi: 10.1111/j.1365-2265.1995.tb01876.x.
10
Osteoporosis in men with hyperprolactinemic hypogonadism.高泌乳素血症性性腺功能减退男性的骨质疏松症
Ann Intern Med. 1986 Jun;104(6):777-82. doi: 10.7326/0003-4819-104-6-777.

引用本文的文献

1
Sex-dependent variation in bone adaptation: from degeneration to regeneration.骨骼适应性的性别差异:从退化到再生
J Orthop Translat. 2025 May 5;52:325-343. doi: 10.1016/j.jot.2025.04.011. eCollection 2025 May.
2
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men.PRDM16通过经典WNT10b/β-连环蛋白途径增强睾酮治疗的性腺功能减退男性的成骨RUNX2。
Biomolecules. 2025 Jan 8;15(1):79. doi: 10.3390/biom15010079.
3
Description of bone health in adolescents and young persons with Klinefelter syndrome - results from a pilot study.
克兰费尔特综合征青少年和青年的骨骼健康描述——一项初步研究的结果
Mol Cell Pediatr. 2024 Sep 17;11(1):9. doi: 10.1186/s40348-024-00182-w.
4
Rare coexistence of hypopituitarism with osteogenesis imperfecta - A double-trouble for bone.垂体功能减退与成骨不全症的罕见共存——骨骼的双重麻烦。
Bone Rep. 2024 Apr 23;21:101768. doi: 10.1016/j.bonr.2024.101768. eCollection 2024 Jun.
5
Association between testosterone levels and bone mineral density in females aged 40-60 years from NHANES 2011-2016.2011 - 2016年美国国家健康与营养检查调查中40 - 60岁女性睾酮水平与骨矿物质密度之间的关联。
Sci Rep. 2022 Sep 30;12(1):16426. doi: 10.1038/s41598-022-21008-7.
6
Androstenedione (a Natural Steroid and a Drug Supplement): A Comprehensive Review of Its Consumption, Metabolism, Health Effects, and Toxicity with Sex Differences.雄烯二酮(一种天然类固醇和药物补充剂):其消费、代谢、健康影响和毒性的全面综述,以及性别差异。
Molecules. 2021 Oct 14;26(20):6210. doi: 10.3390/molecules26206210.
7
JATENZO®: Challenges in the development of oral testosterone.JATENZO®:口服睾酮研发面临的挑战。
Int J Impot Res. 2022 Nov;34(7):721-724. doi: 10.1038/s41443-021-00461-4. Epub 2021 Aug 5.
8
Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.睾酮治疗对 2 型糖尿病性腺功能减退男性骨量和代谢的影响。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3058-e3068. doi: 10.1210/clinem/dgab181.
9
Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review.性腺功能减退症、2 型糖尿病和骨骼健康:叙述性综述。
Front Endocrinol (Lausanne). 2021 Jan 18;11:607240. doi: 10.3389/fendo.2020.607240. eCollection 2020.
10
Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.雄激素和雄激素受体对骨骼健康和疾病的作用:从雄激素缺乏到雄激素治疗。
Cells. 2019 Oct 25;8(11):1318. doi: 10.3390/cells8111318.